C Lemanski
Overview
Explore the profile of C Lemanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
242
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Azria D, Bourgier C, Lemanski C
Cancer Radiother
. 2023 May;
27(3):181-182.
PMID: 37149465
No abstract available.
2.
Vendrely V, Rivin Del Campo E, Modesto A, Jolnerowski M, Meillan N, Chiavassa S, et al.
Cancer Radiother
. 2021 Dec;
26(1-2):272-278.
PMID: 34953708
We present the updated recommendations of the French society of oncological radiotherapy for rectal cancer radiotherapy. The standard treatment for locally advanced rectal cancer consists in chemoradiotherapy followed by radical...
3.
Besnard C, Lemanski C, Vendrely V
Cancer Radiother
. 2021 Oct;
25(8):816-821.
PMID: 34711486
Oncosexuality has recently become a new supportive care mission. Sexual morbidity is, routinely, underestimated and must be questioned. We report here the most frequent disorders for men and for women,...
4.
Rouanet P, Rivoire M, Gourgou S, Lelong B, Rullier E, Jafari M, et al.
Br J Surg
. 2021 Feb;
108(1):10-13.
PMID: 33640922
No abstract available.
5.
Bourgier C, Latorzeff I, Fenoglietto P, Boisselier P, Charissoux M, Llacer C, et al.
Cancer Radiother
. 2019 Sep;
23(6-7):482-485.
PMID: 31495737
We propose in this short review to report the impact of stereotactic body radiation therapy (SBRT) in oligometastatic or oligoprogressive cancer patients in terms of metastatic progression-free and global survival,...
6.
Bourgier C, Lemanski C, Draghici R, Castan F, Fenoglietto P, Bons F, et al.
Cancer Radiother
. 2019 Aug;
23(6-7):778-783.
PMID: 31378461
Randomized trials demonstrated similar overall survival between mastectomy and breast-conservative surgery followed by adjuvant radiation therapy. Breast-conservative surgery, with adjuvant radiation therapy, with or without neoadjuvant systemic therapy has become...
7.
Bourgier C, Lemanski C, Fenoglietto P, Azria D
Cancer Radiother
. 2018 Aug;
22(6-7):478-480.
PMID: 30145090
Standard of care in breast cancer management is well-defined. However, some gray zones still exist, in particular adjuvant radiotherapy indications in case of pN1mi breast cancer. Here we propose to...
8.
Dautruche A, Belin L, Cottu P, Bontemps P, Lemanski C, de la Lande B, et al.
Cancer Radiother
. 2018 Apr;
22(3):222-228.
PMID: 29650388
Purpose: To determine the 3 years late toxicity among patients with non-metastatic breast cancer who received concurrent bevacizumab and locoregional radiotherapy. Material And Methods: This is a single-arm, multicentre, prospective...
9.
Dezellus A, Barriere P, Campone M, Lemanski C, Vanlemmens L, Mignot L, et al.
Eur J Cancer
. 2017 May;
79:72-80.
PMID: 28463758
Aim: Women of reproductive age with breast cancer generally receive gonadotoxic chemotherapy. Fertility issues are of great concern for them. However, little is known on ovarian damage during chemotherapy and...
10.
Bourgier C, Fenoglietto P, Lemanski C, Ducteil A, Charissoux M, Draghici R, et al.
Cancer Radiother
. 2016 Sep;
20(6-7):572-5.
PMID: 27614497
Irradiation techniques for breast cancer (arctherapy, tomotherapy) are evolving and intensity-modulated radiation therapy is being increasingly considered for the management of these tumours. Here, we propose a review of intensity-modulated...